[Experience from uterine cervix sarcoma (author's transl)].
The genital sarcomas of three in 56 Patients (5,36 per cent) were located in the uterine cervix. Treatment gave unsatisfactory results, with survival rates of nine, 13, and 32 months. Suggested are steps by which to improve both the diagnosis and therapy of genital sarcomas in women.
D000328:Adult; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008875:Middle Aged; D012509:Sarcoma / Q000401:mortality / Q000628:therapy*; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*
D003520:Cyclophosphamide
Unsere Erfahrungen mit den Zervix-Sarkomen.